| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000007713 |
| Receipt No. | R000009092 |
| Official scientific title of the study | Assessment of the treatment effect of pregabalin in patients with post-thoracotomy pain |
| Date of disclosure of the study information | 2012/04/10 |
| Last modified on | 2016/12/15 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Assessment of the treatment effect of pregabalin in patients with post-thoracotomy pain | |
| Title of the study (Brief title) | Assessment of the treatment effect of pregabalin in patients with post-thoracotomy pain | |
| Region |
|
|
| Condition | |||
| Condition | Lung cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the usefulness of pregabalin in patients who complain of post-thoracotomy pain after epidural anesthesia. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | VAS at week 2 (Pain at rest, or at coughing) |
| Key secondary outcomes | 1) VAS at day 0 to 7, week 4 and month 3 (Pain at rest, or at coughing)
2) VAS before breakfast, lunch, and dinner at day 2 and 3 (Pain at rest, or at coughing) 3) SF-MPQ (Short-Form McGill Pain Questionnaire) at day 0 and 7, week 2 and 4, and month 3 4) EQ-5D at day 0 to 7, week 2, and 4, and month 3 5) Sleep disorder score (VAS) 6) Incidence of adverse reactions: sleepiness, lightheaded feeling, edema, nausea, vomiting, constipation, and other 7) Number of rescue medication use (codeine phosphate powder 20mg/time and Acetaminophen 400mg/time) 8) Screening tool of neuropathic pain at month 3 |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control group (Standard treatment group): The following treatments for 2 weeks
- Codeine phosphate powder 20mg, TID - Acetaminophen 400mg, TID |
|
| Interventions/Control_2 | Study treatment group (Pregabalin group):
The following treatments for 2 weeks - Codeine phosphate powder 20mg, TID - Acetaminophen 400mg, TID - Pregabalin 75mg, BID |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Lung cancer patients who received thoracotomy
2. Patients who complain of post-thoracotomy pain after 2-day epidural anesthesia (VAS>=40) 3. Patients who are 20 years old or older 4. Patients who agreed to participate in the study and signed informed consent form |
|||
| Key exclusion criteria | 1. Patients with severe renal impairment
2. Patients with pneumothorax or who received mediastinotomy 3. Patients with interstitial pneumonia 4. Patients with history of a previous ipsilateral thoracotomy 5. Patient who used opioid, gabapentine, and/or pregabalin before surgery 6. Other patients considered to be ineligible to participate in the study by the investigator |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroki Iida |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Pain Medicine |
| Address | 1-1 Yanagido, Gifu City, Gifu, 501-1194 |
| TEL | 058-230-6404 |
| mcbyq256@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Noritaka Yoshimura |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Pain Medicine |
| Address | 1-1 Yanagido, Gifu City, Gifu, 501-1194 |
| TEL | 058-230-6404 |
| Homepage URL | |
| mcbyq256@yahoo.co.jp | |
| Sponsor | |
| Institute | Gifu University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Gifu University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | None |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岐阜大学医学部附属病院(岐阜県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009092 |